Idenix Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
08 January 2014 - 12:00AM
Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that
Idenix management will present a corporate overview at the 32nd
Annual J.P. Morgan Healthcare Conference on Wednesday, January 15,
2014 at 11:00 a.m. Pacific Time at the Westin
St. Francis Hotel in San Francisco.
The live and archived webcast of the company presentation can be
accessed under "Events and Presentations" in the Idenix Investor
Center at www.idenix.com. Please log in approximately 5-10 minutes
before the event to ensure a timely connection. The archived replay
will be available on the Idenix website for two weeks following the
conference.
ABOUT IDENIX
Idenix Pharmaceuticals, Inc., headquartered in Cambridge,
Massachusetts, is a biopharmaceutical Company engaged in the
discovery and development of drugs for the treatment of human viral
diseases. Idenix's current focus is on the treatment of patients
with hepatitis C infection. For further information about Idenix,
please refer to www.idenix.com.
CONTACT: Idenix Pharmaceuticals Contact:
Teri Dahlman
(617) 995-9807
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jun 2024 to Jul 2024
(MM) (NASDAQ:IDIX)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More News Articles